BCM
ETNB

Bridgeway Capital Management’s 89bio ETNB Stock Holding History

Bridgeway Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-42,500
Closed -$647K – 1409
2023
Q1 		$647K Sell
42,500
-49,800
-54% -$649K 0.02% 823
2022
Q4 		$1.17M Hold
92,300
– – 0.03% 699
2022
Q3 		$534K Buy
92,300
+32,000
+53% +$141K 0.01% 880
2022
Q2 		$194K Hold
60,300
– – ﹤0.01% 1094
2022
Q1 		$227K Buy
+60,300
New +$388K ﹤0.01% 1150

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bridgeway Capital Management's ETNB Position: Q2 2023 in Review

Bridgeway Capital Management sold out of 89bio (ETNB) in Q2 2023, closing a stake of 42,500 shares — an estimated $647K sold.

Bridgeway Capital Management first reported a position in ETNB in Q1 2022 and held it in 5 quarters. The position peaked at $1.17M in Q4 2022. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

  • Bridgeway Capital Management reported no remaining 89bio position as of Q2 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 42,500 89bio shares in Q2 2023, an estimated $647K.
  • Bridgeway Capital Management first reported a position in 89bio in Q1 2022 and held it in 5 quarters.
  • Bridgeway Capital Management's 89bio position peaked at $1.17M in Q4 2022.
  • 157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.